GBA1 and Parkinson disease: Kaiser et al. identified six differentially expressed proteins in the CSF of GBA1-PD patients compared to unaffected GBA1 mutation careers, which indicates increased neuroinflammatory events linked to the loss of dopaminergic neurons in GBA1-PD [77].